Date:
Friday, December 13, 2019, 4:00pm to 5:00pm
Location:
Radcliffe Institute for Advanced Study, Knafel Center, 10 Garden Street, Cambridge
Xenotransplantation is a promising strategy to address the shortage of organs for human transplantation, though concerns about pig-to-human immunological compatibility and the risk of cross-species transmission of porcine endogenous retroviruses (PERVs) have impeded the clinical application of this approach. In this lecture, Luhan Yang, cofounder and chief scientific officer of eGenesis will explain how CRISPR is being used to create pigs with advanced immunological modifications to address immunological and functional compatibility issues.
This event is free and open to the public, but registration is required.